Home / News / Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO

Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO

Read the full article: Global News Wire

12 January 2026

Posted in — News, The Australian Financial Review

Share
Share

You may also like

15 October 2025

Accel-KKR Acquires Phocas Software

News, The Australian Financial Review

04 September 2025

Australian Investment Council announces 2025 investing for growth award winners

News

09 October 2025

The List: Top 100 Innovators 2025

News, The Australian

01 April 2025

OneVentures-backed artificial heart start-up rattles the tin for $100m

News, The Australian Financial Review

View All

Ventured. Gained.
decor